A new antifungal antibiotic, S-632-C, was extracted with ethyl acetate from the culture filtrate of Streptomyces hygroscopicus S-632 and isolated through a combination of column and preparative thin-layer chromatographies on silica gel. The structure of S-632-C was determined by analysis of XHand 13C-NMR,MS, UVand IR spectra in comparison with those of S-632-A2 (9-methylstreptimidone). The signals were assigned on the basis of 2D NMR experiments, which involved^^H DQFCOSY,HMQC and HMBC spectral analysis. From these results, the chemical structure of S-632-C was elucidated as 6-(3,5-dimethyl-2-oxo-4,6-octadienyl)-4-carbamoylmethyl-3,4,5,6-tetrahydro-2-pyrone.
A new antifungal antibiotic, S-632-C, was extracted with ethyl acetate from the culture filtrate of Streptomyces hygroscopicus S-632 and isolated through a combination of column and preparative thin-layer chromatographies on silica gel. The structure of S-632-C was determined by analysis of XHand 13C-NMR,MS, UVand IR spectra in comparison with those of S-632-A2 (9-methylstreptimidone). The signals were assigned on the basis of 2D NMR experiments, which involved^^H DQFCOSY,HMQC and HMBC spectral analysis. From these results, the chemical structure of S-632-C was elucidated as 6-(3,5-dimethyl-2-oxo-4,6-octadienyl)-4-carbamoylmethyl-3,4,5,6-tetrahydro-2-pyrone.
The antibiotic exhibited exclusively weak in vitro antifungal activity against Saccharomycesspp. and similar cytotoxic activity against KBcarcinoma cells, as compared with the glutarimide antibiotic S-632-A2. In addition, this antibiotic had the ability to change the morphology of rasts-transformed NRKcells to that of normal cells, also a characteristic S-632-A2 andBj.
During our screening program for new antibiotics, we found that Streptomyces hygroscopicus S-632 produced a mixture of homogeneous antifungal antibiotics. In preceding papers1'2*, we described the isolation of four biologically active compounds, S-632-Ai (streptimidone), -A2 (9-methylstreptimidone), -Bl9 and -B2. S-632-Bi and -B2 were found to be two stereoisomers of new members of the glutarimide family of antibiotics. This paper deals with the isolation, structural determination, and biological activities of an additional component, S-632-C produced by this strain. S-632-C is a novel antifungal antibiotic structurally related to glutarimide antibiotics (Scheme 1).
Materials and Methods

Fermentation
Fermentation conditions were essentially the same as in the previous method1*, except for use of a rotary shaker. The progress of the fermentation was monitored by growth inhibition against Saccharomyces cerevisiae by the conventional paper disk-agar plate method, and the fermentation process reached its maximumafter 120 hours of cultivation. The ratio of the antibiotics was determined by the HPLCmethod described previously2). 
Isolation
The fermentation broth was centrifuged at 2,800 rpm for 10 minutes and filtered to remove the mycelial cake. The filtered broth (1 1 liters) was adjusted to pH 7.0 with 0.1 n NaOHand then extracted twice with ethyl acetate. The extract was dried over anhydrous Na2SO4and evaporated to dryness in vacuo to give 4.6 g of oily residue. The isolation of respective components was performed by a purification procedure that was an improvementover the previous method2), as follows. Theresidue was applied on a silica gel column (45 x 6.0cm, i.d.), and then eluted stepwise with a series of benzene-acetone from 9 : 1 to acetone. The active fractions containing S-632-A2, which eluted with benzene -acetone (8 : 2), were concentrated in vacuo to yield 1,019mg of crude oil. The following active fractions containing S-632-Bx and -B2, eluted with benzene-acetone (7 : 3), were concentrated in vacuo to give 324.3mg of crude oil. The objective S-632-C was eluted with benzene -acetone (5 : 5), and the corresponding fractions were concentrated in vacuo to yield 177.5mg of crude oil. Further purification of the crude S-632-A2 (90.2mg) was achieved by preparative TLCon Silica gel 60PF254 (Merck) with benzene-acetone (3 : 1) as the developing solvent, to obtain 53.8mg of S-632-A2. The S-632-Bj and -B2 (60.5 mg) were also obtained as a mixture of diastereomers (53.9mg) by preparative TLC and separated by preparative HPLC on a Unisil Q C18 column (250 x 4.6mm, i.d., Gasukuro Kogyo) with MeOH-water (50: 50) as a mobile phase, to obtain S-632-Bi (4.6mg) and S-632-B2 (1.1mg). The crude material containing S-632-C was purified by preparative TLCon silica gel with hexane -acetone (3 : 2) as the developing solvent. The active band corresponding to Rf0.4 was scraped off and after extraction from the gel with acetone, purified S-632-C (42.4mg) was isolated. S-632-A1? -A2, -B1? and -B2 were members of the glutarimide family of antibiotics and we have reported their structures as corresponding to streptimidone3), 9-methylstreptimidone4'5), and two diastereomers of 8,9-epoxy-9-methylstreptimi-
Instrumental Analysis Analysis by HPLC was performed with a Hitachi L-6200 Intelligent pump system on a Unisil Q C18 column (250x4.6mm, i.d.) at UV-210nm with MeOH-water (50: 50) used as a mobile phase. Optical rotation was measured in chloroform at 25°C on a Horiba SEPA-200polarimeter.
UVand IR spectra were recorded in MeOHon a Shimadzu Double-beam Spectrophotometer UV-180 and in KBr pellets on a Perkin Elmer FT-IR Spectrometer 1760X, respectively. *H and 13C-NMRspectra were recorded in CDC13on JEOL GSX-400 and JEOLGX-270 FT-NMRSpectrometers, respectively. El-Mass spectrum was obtained on a JEOLDX-303spectrometer.
Biological Activities
The in vitro antimicrobial activities of components S-632-C and 9-methylstreptimidone were determined by a serial agar dilution method in nutrient agar (Difco) for bacteria and in Sabouraud's agar (Nissui) for filamentous fungi and yeasts. Minimum inhibitory concentration (MIC) was observed after overnight incubation 37°C and 2~3 days incubation at 27°C, respectively. For the in vitro cytotoxicity assay, KBcells were maintained in Eagle's minimal essential medium (MEM) supplemented with 10% fetal calf serum and 100 /ig/ml kanamycin. The cells (2 x 104 cells/ml) were incubated for 24 hours before addition of the compounds tested. The various concentrations of test compoundswere added on day 1, and the concentration of the compoundrequired for 50%inhibition of cell growth (IC50, //g/ml) was determined by plotting a semi-log of the drug concentration (jug/ml) vs. percent of the growth rate of treated cells.
Cells of the rat kidney cell line (NRK) infected with ts371 murine sarcoma virus (ra.?tsNRK)6) were cultured at either permissive temperature (33°C) or nonpermissive temperature (39°C) in Dulbecco's modified MEMsupplemented with 5% heat-inactivated calf serum and 100/ig/ml kanamycin. The cells were seeded into Costar 24-well tissue culture clusters at 1.5 x 104cells/ml/well and cultured for 1 day at 33°C in a 5%CO2-95%air incubator. Solutions of various concentrations of test samples were added on day 1, and after incubation for 2 days the rasts-NRK cells were observed microscopically for evidence of morphological reversion.
Results and Discussion
Physico-chemical Properties and Structure Determination of S-632-C Physico-chemical properties of S-632-C in comparison with those of S-632-A2 are summarized in Table 1 . This component was distinguished from S-632-A2 by HPLCand TLC mobilities. It was soluble in methanol, ethyl acetate, acetone and chloroform, but insoluble in hexane and water. It showed positive color reactions with H2SO4,KMnO4, ninhydrin reagents and iodine vapor, and a negative reaction with Dragendorf's reagent. The UVspectrum of S-632-C exhibited an absorption maxima, at 234nm, very close to one of S-632-A2, 231.5nm, which corresponds to a conjugated diene system as is present in S-632-A2 (9-methylstreptimidone).
As shown in the IR spectrum ( Fig. 1) , characteristic IR absorption at carbonyl and amide/imide groups. The molecular formula of S-632-C was determined to be C17H25NO4 (MW 307) by high resolution electron impact mass spectrometry (HREI-MS), which was the same as that of 9-methylstreptimidone. The EI-MS of S-632-C gave the same molecular ion peak (M+) at m/z 307, along with abundant fragment ion peaks at m/z 198 (C9H12NO4), m/z 180 (C9H10NO3) and m/z 109 (C8H13). It showed a fragment pattern almost identical to that commonly observed for the glutarimide group antibiotics, as reported previously2). Therefore, S-632-C was deduced to be a structural isomer of 9-methylstreptimidone.
The structure was elucidated from the^-NMR, 13C-NMRand WHDQFCOSYspectral analysis, and from the results of the HMBC and HMQC experiments. The^-NMRspectrum of S-632-C showed fifteen signals due to three methyl, four methylene, six methine and two NHprotons. The 13C-NMR spectrum exhibited seventeen signals consisting of three methyl, four methylene, three methine, four olefinic and three carbonyl carbons. The correlation between protons and carbons revealed by the HMQC spectrum of S-632-C is presented in Table 2 , where it is compared with that for S-632-A2. It was, however, impossible to assign exactly the two carbonyl signals at 171.3 and 172.7ppm in the 13C-NMR spectrum of S-632-C. Thus, we performed a deuterium exchange experiment using the method of Newmarket al?) to distinguish the two carbonyl signals. The latter signal was observed as two peaks and one diminutive shoulder, and the C-3' methylene signal was split into two peaks, due to the isotope effect by deuterium exchange of carbamoyl group in CD3OD-CD3OH (1 : 1) solution, while the former signal remained. Therefore, we clarified that the former carbonyl signal was due to an ester carbonyl group and the latter carbonyl signal was due to a carbamoyl carbonyl group.
In the^^H DQF COSYspectrum,^^H coupling correlation were observed among 5-CH3, 5-H, a These data were measured in this study. 6-H, 7-CH3, 8-H, 9-H and 9-CH3, and 3-H, 5-H, 4'-H, 1-H, 2-H and 3-H. In the HMBCspectrum, long-range^-^C coupling was observed between 1-H and 2-C; 2-H and 4'-C; 3-H and 2-C, 4-C; 5-CH3 and 4-C, 5-C, 6-C; 5-H and 4-C, 6-C; 7-CH3 and 6-C, 7-C, 8-C; 9-CH3 and 8-C, 9-C; 3-H and 2'-C; 4'-H and 1-C, 2'-C, 3'-C, 6'-C; 5 -H and 1-C, 4'-C, 6'-C (Fig. 2) . The degree ofunsaturation of S-632-C was estimated as six from its molecular formula. The structure of this antibiotic must contain five double bonds and one ring structure. Accordingly, the chemical structure of S-632-C was determined to be 6-(3,5-dimethyl-2-oxo-4,6-octadienyl)-4-carbamoyl methyl-3,4,5,6-tetrahydro-2-pyrone, which leads to the structure as shown in Scheme1.
Biological Activities The antifungal spectrum of S-632-C is shown in Table 3 , in comparison with that of S~632-A2. S-632-C displayed specific activity against Saccharomyces spp., although its activity was less than that of S-632-A2. It was devoid of any significant activity against other fungi and bacteria. DEC. 1993 The IC50 values of S-632-A2 and C were the same, 0.2/ig/ml, when KB cells were exposed to these agents for 3 days. Amongthe compounds isolated so far, S-632-Bi has the highest cytotoxic activity, as shown in a previous report1}.
Furthermore, in screening inhibitors for inhibition of oncogene functions, we found that S-632-Bi converted the transformed morphology of?WSNRK cells6) back to the normal cell morphology at 33°C, the permissive temperature, at a concentration (0. 1 jug/ml) that inhibited the cell growth only partially (Fig.   3D ). Someglutarimide antibiotics, such as acetoxycycloheximide, cycloheximide8) and epiderstatin9' 1 0) have also been reported to alter the morphology of ras-transformed cells. Since S-632-C, a weaker inhibitor of the growth of rastsNRK cells, also displayed this activity (Fig. 3E) , the glutarimide ring may not be an essential structure to cause this morphological reversion.
